BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 21224071)

  • 1. Unexpected reduction of skin tumorigenesis on expression of cyclin-dependent kinase 6 in mouse epidermis.
    Wang X; Sistrunk C; Rodriguez-Puebla ML
    Am J Pathol; 2011 Jan; 178(1):345-54. PubMed ID: 21224071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CDK2 activation in mouse epidermis induces keratinocyte proliferation but does not affect skin tumor development.
    Macias E; Miliani de Marval PL; De Siervi A; Conti CJ; Senderowicz AM; Rodriguez-Puebla ML
    Am J Pathol; 2008 Aug; 173(2):526-35. PubMed ID: 18599613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cdk4 deficiency inhibits skin tumor development but does not affect normal keratinocyte proliferation.
    Rodriguez-Puebla ML; Miliani de Marval PL; LaCava M; Moons DS; Kiyokawa H; Conti CJ
    Am J Pathol; 2002 Aug; 161(2):405-11. PubMed ID: 12163365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin D3 deficiency inhibits skin tumor development, but does not affect normal keratinocyte proliferation.
    Lee SH; Wang X; Kim SH; Kim Y; Rodriguez-Puebla ML
    Oncol Lett; 2017 Sep; 14(3):2723-2734. PubMed ID: 28927034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cdk2 deficiency decreases ras/CDK4-dependent malignant progression, but not myc-induced tumorigenesis.
    Macias E; Kim Y; Miliani de Marval PL; Klein-Szanto A; Rodriguez-Puebla ML
    Cancer Res; 2007 Oct; 67(20):9713-20. PubMed ID: 17942901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of cyclin-dependent kinase 4 inhibits c-myc tumorigenic activities in epithelial tissues.
    Miliani de Marval PL; Macias E; Rounbehler R; Sicinski P; Kiyokawa H; Johnson DG; Conti CJ; Rodriguez-Puebla ML
    Mol Cell Biol; 2004 Sep; 24(17):7538-47. PubMed ID: 15314163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transgenic expression of cyclin-dependent kinase 4 results in epidermal hyperplasia, hypertrophy, and severe dermal fibrosis.
    Miliani de Marval PL; Gimenez-Conti IB; LaCava M; Martinez LA; Conti CJ; Rodriguez-Puebla ML
    Am J Pathol; 2001 Jul; 159(1):369-79. PubMed ID: 11438484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin-dependent kinase 4 expression is essential for neu-induced breast tumorigenesis.
    Reddy HK; Mettus RV; Rane SG; Graña X; Litvin J; Reddy EP
    Cancer Res; 2005 Nov; 65(22):10174-8. PubMed ID: 16288002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased IKKα expression in the basal layer of the epidermis of transgenic mice enhances the malignant potential of skin tumors.
    Alameda JP; Moreno-Maldonado R; Fernández-Aceñero MJ; Navarro M; Page A; Jorcano JL; Bravo A; Ramírez Á; Casanova ML
    PLoS One; 2011; 6(7):e21984. PubMed ID: 21755017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constitutive expression of erbB2 in epidermis of transgenic mice results in epidermal hyperproliferation and spontaneous skin tumor development.
    Kiguchi K; Bol D; Carbajal S; Beltrán L; Moats S; Chan K; Jorcano J; DiGiovanni J
    Oncogene; 2000 Aug; 19(37):4243-54. PubMed ID: 10980598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclin D1 and cyclin D-dependent kinases enhance oral keratinocyte proliferation but do not block keratinocyte differentiation.
    Woods M; Pant R; Mallya SM
    Int J Oncol; 2010 Dec; 37(6):1471-5. PubMed ID: 21042715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paradoxical tumor inhibitory effect of p53 loss in transgenic mice expressing epidermal-targeted v-rasHa, v-fos, or human transforming growth factor alpha.
    Greenhalgh DA; Wang XJ; Donehower LA; Roop DR
    Cancer Res; 1996 Oct; 56(19):4413-23. PubMed ID: 8813135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constitutive activation and targeted disruption of signal transducer and activator of transcription 3 (Stat3) in mouse epidermis reveal its critical role in UVB-induced skin carcinogenesis.
    Kim DJ; Angel JM; Sano S; DiGiovanni J
    Oncogene; 2009 Feb; 28(7):950-60. PubMed ID: 19137019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A requirement for cyclin-dependent kinase 6 in thymocyte development and tumorigenesis.
    Hu MG; Deshpande A; Enos M; Mao D; Hinds EA; Hu GF; Chang R; Guo Z; Dose M; Mao C; Tsichlis PN; Gounari F; Hinds PW
    Cancer Res; 2009 Feb; 69(3):810-8. PubMed ID: 19155308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of Cdk6-cyclin D3 highly sensitizes cells to physical and chemical transformation.
    Chen Q; Lin J; Jinno S; Okayama H
    Oncogene; 2003 Feb; 22(7):992-1001. PubMed ID: 12592386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced malignant tumorigenesis in Cdk4 transgenic mice.
    Miliani de Marval PL; Macias E; Conti CJ; Rodriguez-Puebla ML
    Oncogene; 2004 Mar; 23(10):1863-73. PubMed ID: 14647432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deregulated expression of E2F1 induces hyperplasia and cooperates with ras in skin tumor development.
    Pierce AM; Fisher SM; Conti CJ; Johnson DG
    Oncogene; 1998 Mar; 16(10):1267-76. PubMed ID: 9546428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of DeltaNLef1 in mouse epidermis results in differentiation of hair follicles into squamous epidermal cysts and formation of skin tumours.
    Niemann C; Owens DM; Hülsken J; Birchmeier W; Watt FM
    Development; 2002 Jan; 129(1):95-109. PubMed ID: 11782404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin D1 overexpression in mouse epidermis increases cyclin-dependent kinase activity and cell proliferation in vivo but does not affect skin tumor development.
    Rodriguez-Puebla ML; LaCava M; Conti CJ
    Cell Growth Differ; 1999 Jul; 10(7):467-72. PubMed ID: 10437914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of Cdk6 and Ccnd1 in chondrocytes inhibited chondrocyte maturation and caused p53-dependent apoptosis without enhancing proliferation.
    Ito K; Maruyama Z; Sakai A; Izumi S; Moriishi T; Yoshida CA; Miyazaki T; Komori H; Takada K; Kawaguchi H; Komori T
    Oncogene; 2014 Apr; 33(14):1862-71. PubMed ID: 23624920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.